The tariff classification of Lexapro™ (escitalopram oxalate) tablets from Ireland
Reasoning
The tariff classification of Lexapro™ (escitalopram oxalate) tablets from Ireland
Cite this ruling
CBP Ruling H88713 (3004909135): The tariff classification of Lexapro™ (escitalopram oxalate) tablets from Ireland
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of cough suppressant lozenges from England.
The tariff classification of dietary supplements from Italy
The tariff classification of IQUIX® (levofloxacin ophthalmic solution) 1.5%, imported in bulk and measured-dose forms, from Finland
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use
The tariff classification of Pulmozyme® (dornase alfa) Inhalation Solution; Raptiva® (Efalizumab) for injection, subcutaneous; Rituxan® (Rituximab); TNKase™ (Tenecteplase); and Xolair® (Omalizumab) for subcutaneous use